Yüklüyor......
Acquired Resistance to Immune Checkpoint Blockade Therapies
Immune checkpoint blockade therapy (ICBT) has revolutionized the treatment and management of numerous cancers, yet a substantial proportion of patients who initially respond to ICBT subsequently develop resistance. Comprehensive genomic analysis of samples from recent clinical trials and pre-clinica...
Kaydedildi:
| Yayımlandı: | Cancers (Basel) |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280955/ https://ncbi.nlm.nih.gov/pubmed/32380703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051161 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|